Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients: A phase II study of the Gruppo Oncologico dell' Italia Meridionale (GOIM)

Authors
Category Primary study
JournalEuropean Journal of Cancer, Supplement
Year 2008
This article has no abstract
Epistemonikos ID: ba6bfbfc490d5853a3d493ce2ac76467afb1c4a4
First added on: Feb 04, 2025